Most Popular
-
1
[Exclusive] Korean military set to ban iPhones over 'security' concerns
![[Exclusive] Korean military set to ban iPhones over 'security' concerns](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/23/20240423050599_0.jpg&u=20240423183955)
-
2
Korean, Romanian leaders discuss defense tech, nuclear energy
-
3
S. Korea calls on Japan to confront history amid Yasukuni Shrine visit
-
4
Yoon’s jailed mother-in-law excluded from latest parole list
-
5
Hybe and Min Hee-jin, CEO of Hybe sublabel Ador, lock horns
![[Exclusive] Korean military set to ban iPhones over 'security' concerns](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/23/20240423050599_0.jpg&u=20240423183955)
-
6
[Pressure points] Leggings in public: Fashion statement or social faux pas?
![[Pressure points] Leggings in public: Fashion statement or social faux pas?](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/23/20240423050669_0.jpg&u=)
-
7
Korea’s homegrown nanosatellite successfully launches into space
-
8
[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'
![[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/24/20240424050844_0.jpg&u=20240424200058)
-
9
Nicaragua shuts down Seoul embassy
-
10
Rocket engine expert, ex-NASA exec to lead Korea's new space agency
![[Pressure points] Leggings in public: Fashion statement or social faux pas?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/23/20240423050669_0.jpg&u=)
![[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/24/20240424050844_0.jpg&u=20240424200058)
Janssen Korea on Monday launched Sirturo, a treatment for multi-drug-resistant tuberculosis.
Sirturo has been shown to reduce the treatment period by 42 days compared to conventional treatment using drugs normally prescribed in Korea. In a clinical test, it cured 57.9 percent of tested people within 120 weeks.
The drug was approved by the Korea Food and Drug Administration on March 21.
In Korea, 1,212 people reportedly contract MDR-TB every year. Korea’s MDR-TB prevalence and death rate from the disease is the highest among OCED states.
(baejisook@heraldcorp.com)
Sirturo has been shown to reduce the treatment period by 42 days compared to conventional treatment using drugs normally prescribed in Korea. In a clinical test, it cured 57.9 percent of tested people within 120 weeks.
The drug was approved by the Korea Food and Drug Administration on March 21.
In Korea, 1,212 people reportedly contract MDR-TB every year. Korea’s MDR-TB prevalence and death rate from the disease is the highest among OCED states.
(baejisook@heraldcorp.com)
-
Articles by Korea Herald
